Fibrosis as an End Point for Clinical Trials in Liver Disease: A Report of the International Fibrosis Group
- 31 October 2006
- journal article
- review article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 4 (10) , 1214-1220.e1
- https://doi.org/10.1016/j.cgh.2006.07.006
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Performance of serum marker panels for liver fibrosis in chronic hepatitis CJournal of Hepatology, 2006
- Intrahepatic gene expression profiles and alpha‐smooth muscle actin patterns in hepatitis C virus induced fibrosis†Hepatology, 2005
- Sources of variability in histological scoring of chronic viral hepatitis†Hepatology, 2005
- Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis CClinical Chemistry, 2004
- DIVERGENT PATTERNS OF EXTRACELLULAR MATRIX PROTEIN EXPRESSION IN NEONATAL VERSUS ADULT LIVER FIBROSISPediatric Pathology & Molecular Medicine, 2003
- Sampling Variability on Percutaneous Liver Biopsy in Patients with Chronic Hepatitis C Virus InfectionScandinavian Journal of Gastroenterology, 2003
- Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis BJournal of Hepatology, 2001
- The effects of increassing doses of ranitidine on intragastric pH in childrenGastroenterology, 2001
- Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 yearsJournal of Hepatology, 1994
- The Prognostic Importance of Clinical and Histologic Features in Asymptomatic and Symptomatic Primary Biliary CirrhosisNew England Journal of Medicine, 1983